I n community practice settings, noninvasive stress testing is performed in >35% of patients within 1 year of percutaneous coronary intervention (PCI) with rates approaching 70% at some hospitals. 1, 2 In the absence of new or progressive symptoms, appropriate use criteria consider stress testing within 2 years of PCI to be inappropriate. 3 As the rate of recurrent symptoms at 1 year after PCI is ≈20%, 4 there is concern that noninvasive stress tests after PCI are overused in community practice.
for underuse of stress testing by exploring the association between hospital stress testing rates and patient outcomes of mortality and myocardial infarction (MI).
Methods

Study Setting
The Veterans Affairs (VA) Clinical Assessment, Reporting, and Tracking (CART) Program is the national clinical quality program for all VA cardiac catheterization laboratories. The CART Program uses a software application that is embedded within the VA electronic health record to collect patient and procedural data at the point-ofcare for all PCIs performed in the VA. [7] [8] [9] These data are linked to the VA electronic health record, allowing for linkage to longitudinal mortality, hospitalization, outpatient visit, medication, and laboratory data. In addition, the CART data are linked to fee-based data to determine non-VA care when the VA pays for the Veterans' care. A previous study has demonstrated the validity of CART data. 7
Patient and Hospital Inclusion Criteria
We evaluated all Veterans undergoing PCI in VA between October 1, 2007 and July 2, 2010 to ensure at least 2 years of follow-up data were available after the procedure. As patients >65 years are eligible for Medicare in addition to the VA, we restricted our analysis to 10 975 patients who were not Medicare eligible during the follow-up period (ie, age <63 years at the onset of observation) to avoid the potential influence of stress testing performed in Medicare influencing the apparent use of stress testing within the VA. We excluded 514 (4.7%) patients with missing PCI indication (acute and elective) as this was a determinant of the likelihood of follow-up stress testing in previous analyses. Consistent with previous studies, we also excluded 119 (1.1%) patients who died within 60 days of PCI as they were not eligible for follow-up stress testing in the follow-up period of interest (see Stress Test Use section in this article). Finally, to avoid inflation of variance in facility-level analyses because of small numbers, we also excluded 49 (0.5%) patients from 4 facilities that performed <50 PCI during the study period. Our final cohort for analysis included 10 293 patients from 55 hospitals.
Stress Test Use
Use of stress testing in the 2 years after PCI was identified from the VA Corporate Data Warehouse 10 using Current Procedural Terminology (CPT) and International Classification of Diseases, Ninth Revision codes for stress echocardiography (93350, 93351, C8928, C8930), ECG or pharmacological stress tests (93015, 93016, 93017, 93018,  89.41-89.43), myocardial nuclear imaging (78451-78454, 78460,  78461, 78464, 78465, 78472, 78473, 78481, 78483, 78491, 78492,  89.44), or stress magnetic resonance imaging (75559, 75560 , 75563, 75564) for any care delivery visit paid for by VA. Consistent with previous studies, ECG or pharmacological stress and nuclear imaging procedures performed within 72 hours of each other were considered a single stress test event and ECG or pharmacological stress and echocardiographic or magnetic resonance imaging testing performed on the same day were considered a single stress test event. 2 Consistent with previous studies, a 60-day blackout period after PCI was imposed for each patient because stress tests performed during this period may be performed for the purposes of cardiac rehabilitation, staging of procedures, or functional capacity assessments. 1, [11] [12] [13] 
Use of Coronary Angiography and PCI
Using CPT and International Classification of Diseases, Ninth Revision codes, we identified computed tomographic coronary angiography, coronary angiography, PCI, and coronary artery bypass graft surgery that occurred in follow-up of the index PCI (see Data Supplement for list of codes). As with assessment of stress test use, a 60-day blackout window after the index PCI was defined for each patient. We identified the date of coronary angiography and revascularization procedures to define (1) the population of patients where repeat coronary angiography or revascularization preceded a stress test in the follow-up period and (2) the proportion of patients that underwent additional invasive evaluation or treatment in response to stress test results as evidenced by angiography or revascularization within 90 days of a stress test.
All-Cause Mortality and Acute MI
Clinical outcomes of all-cause mortality and MI were determined for the time period from 60 days through 2 years after PCI. This time period was chosen to correspond to the period of ascertainment for follow-up stress testing after PCI. Death was determined from the VA Information Resource Center Vital Status File, 14 which compiles data from the Beneficiary Identification Records Locator Subsystem Death file, VA Medicare Vital Status File, and the Social Security Administration Death Master File while MI was ascertained from VA administrative inpatient data records.
Statistical Analysis
We determined the overall proportion of patients that underwent stress testing within 24 months of PCI and summarized the proportion of patients that received stress testing without imaging, stress testing with nuclear imaging, or stress echocardiography. We next compared patient demographic, clinical characteristics, use and timing of coronary angiography, or revascularization relative to stress testing. Comparisons were conducted using χ 2 tests for categorical variables and t tests for continuous variables. We identified patient factors associated with greater use of stress testing using hierarchical logistic regression with a random intercept for hospital to account for clustering of patients by site. To describe the timing of stress testing after PCI, we calculated cumulative incidence of stress testing in follow-up and the 30-day incremental incidence (ie, the incidence of first stress test in 30-day windows of follow-up) to identify periods of higher stress testing use.
We compared patient and hospital characteristics by the hospital quartile of cumulative incidence of stress testing within 2 years of the index PCI. Comparisons of patient characteristics were completed using analysis of variance for continuous variables and χ 2 test for categorical variables. Hospital characteristics were compared using the Kruskal-Wallis test for continuous variables and χ 2 or Fisher exact test for categorical variables. Finally, we determined hospital-level variation in risk-standardized rates of stress testing in follow-up of the index PCI using Bayesian methods. 15 The Bayesian approach tends to be more conservative (more specific and less sensitive) than other approaches of identifying variation by facility. [16] [17] [18] Bayesian profiling of standardized stress testing rates was modeled using a Markov chain Monte Carlo method (with a single chain of 5000 burn in iterations and 50 000 estimation iterations retaining every 10th observation for
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a total sample of 5000) to obtain standardized stress testing rates and 95% credible intervals for each hospital. All models included hospital random intercepts to account for clustering of patients within hospitals, and for use in calculating hospital estimates of risk-standardized ratios, and adjusted for patient-level covariates, including demographics (age, sex, and race), clinical risk factors, and cardiovascular history (previous MI, previous coronary artery bypass graft, previous PCI, tobacco use, diabetes mellitus, hypertension, hyperlipidemia, peripheral arterial disease, cerebral vascular disease, congestive heart failure, obesity/ overweight, chronic obstructive pulmonary disease, and dialysis, depression), PCI characteristics [indication, severity of coronary artery disease (CAD; 1-vessel, 2-vessel, 3-vessel/left main], stent type, and calendar year of stress test, all of which were chosen a priori based on clinical judgment and previously published studies. 1 Severity of CAD was missing for 1247 (12.1%) of patients and values were imputed using a multinomial logistic model with a generalized logit link function that estimated the relative probability of each category of CAD severity (ie, 1-vessel, 2-vessel, or 3-vessel/left main) based on patient covariates for age, diabetes mellitus, hypertension, hyperlipidemia, tobacco use, race, sex, and obesity. A category of CAD severity was assigned when values were missing based on the relative probabilities from this model. This simple imputation approach was used in given practical challenges of multiple imputation in a Bayesian framework. Furthermore, using frequentist methods, the impact of multiple imputation on parameter estimates was minor relative to simple imputation. We repeated these analyses to determine facility-level riskstandardized mortality and MI rates during the 2-year period of follow-up. We then determined the correlation between hospital-level risk-adjusted rates of stress testing with risk-adjusted mortality and MI rates. Statistical analyses were performed with SAS/STAT software, version 9.4 of the SAS System for Windows and R versions 2.15.2 and 3.1.1 (http://cran.r-project.org) and all statistical tests were evaluated at a significance level of 0.05. This study was approved by the Colorado Multiple Institutional Review Board.
Results
Stress Testing Versus No Stress Testing
Among 10 293 patients undergoing PCI, 2239 (21.8%) has a stress test performed in the subsequent year and 3902 (37.9%) had a stress test performed in the subsequent 2 years. In patients who underwent stress testing, 634 (16.2%) were performed without imaging, 3115 (79.8%) were performed with nuclear imaging, 149 (3.8%) with echocardiography, and 4 (<0.1%) with magnetic resonance imaging. Most comparisons of patient characteristics, clinical presentation, use and timing of coronary angiography, and PCI by presence or absence of follow-up stress testing were statistically significant given our large sample size, but differences were clinically modest ( Table 1) . A notable exception was the higher prevalence of concurrent depression among patients who underwent followup stress testing as compared with patients with no follow-up stress test (45.3% versus 40.8%; P<0.001).
Among patients who underwent stress testing in 2 years of follow-up, 555 (14.2%) had repeat coronary angiography before stress testing while 271 (6.9%) had repeat PCI before stress testing. In the 90 days subsequent to follow-up stress testing, 753 (19.3%) underwent coronary angiography and 355 (9.1%) underwent PCI. Few patients underwent coronary artery bypass graft either before (n=40, 1.0%) or subsequent (n=62, 1.6%) to follow-up stress testing. Patient factors associated with higher stress testing use are shown in the Data Supplement ( Table I in the Data Supplement).
The cumulative incidence of stress testing is shown in Figure 1 . A plot of the 30-day incremental incidence of stress testing ( Figure 2 ) suggested no large spikes in temporal use of stress testing during the period of follow-up. This did not vary by hospital quartile of stress testing use ( Figure A in the Data Supplement).
Hospital Rates of Stress Testing Use
The median hospital rate of stress testing in the 2 years after PCI was 38.3%, with a range from 26.5% to 59.0%. By hospital quartile of stress testing in follow-up, the median rate of stress testing in follow-up was 29% in the lowest quartile, 37% in the second lowest quartile, 41% in the second highest quartile, and 47% in the highest quartiles ( Table 2) .
Although most comparisons of patient demographics, cardiovascular risk factors, and comorbid conditions by quartile of stress testing use in follow-up were statistically significant given our large sample size, there were no notable differences across hospital quartiles ( Table 2) . Hospitals with higher rates of stress testing in follow-up had a lower acuity of presentation for the index PCI at hospitals with higher rates of stress testing use in follow-up, including fewer PCI for ST-segmentelevation MI. In the 2 years after PCI, computed tomographic coronary angiography was used in <1% of patients in all hospital quartiles. Hospital quartiles with lower stress testing use had higher rates of coronary angiography and PCI before follow-up stress testing, suggesting invasive procedures may have replaced some use of noninvasive testing at facilities with lower rates of use. Rates of coronary artery bypass graft either before or subsequent to stress testing appeared similar across hospital quartiles of stress test use.
After risk adjustment, facility-level risk-standardized rates of stress testing in 2 years of follow-up of the index PCI are shown in Figure 3 . Risk-standardized rates of stress testing varied from 28.5% (95% credible interval, 24.9%-32.6%) to 55.2% (95% credible interval, 48.2%-62.5%). A total of 14 (25.5%) hospitals had a risk-standardized rate of stress testing use that differed significantly from the average, with 8 (14.5%) hospitals being significantly below and 6 (10.9%) hospitals being significantly above the average rate of stress testing.
Rates of Stress Testing in Relation to Patient Outcomes
In the period from 60 days after PCI through 2 years, 528 patients (5.1%) died and 459 (4.5%) had an MI. In the comparison of hospital risk-standardized rates for all-cause mortality and MI, there were no statistically significant outliers ( Figure  B in the Data Supplement). The facility-level risk-standardized rate of stress testing was not significantly correlated with facility-level risk-standardized mortality (Spearman ρ=−0.24; P=0.08) or MI rates (Spearman ρ=0.20; P=0.14).
Discussion
Among patients undergoing PCI in the VA, we sought to describe overall use of stress testing in the 2 years after PCI, hospital-level variation in stress testing use, and the relationship between hospital rates of stress testing and patient outcomes of mortality and MI. In a national sample of >10 000 patients undergoing PCI at 55 VA hospitals, 22% underwent a stress test in the year after PCI and 38% underwent a stress test in the subsequent 2 years. Hospital rates of stress testing after PCI varied considerably, with risk-standardized rates of use ranging from 29% to 55%. Among facilities with lower rates of stress testing, we observed higher rates of coronary angiography, suggesting some use of noninvasive testing was replaced by invasive diagnostic procedures. Rates of stress testing were not significantly associated with all-cause mortality or MI. Understanding the causes and consequences of variation in stress testing use within the VA may inform emerging care delivery models that emphasize healthcare integration in a non fee-for-service reimbursement setting.
In the absence of new or progressive symptoms, stress testing is considered inappropriate in the 2 years after PCI. 3 Previous studies suggest ≈20% of patients suffer recurrent angina in the year after PCI. 4 Studies from the fee-for-service setting have found a rate of stress testing after PCI that exceeds this rate of recurrent symptoms, with >35% of patients undergoing stress testing within 1-year and nearly 60% undergoing stress testing within 2 years of PCI. 1, 2 Furthermore, previous studies have demonstrated temporal spikes in stress test use at 6 months and 1 year after PCI, suggesting the use of routine screening stress tests at the time of follow-up visits. 2, 11 In contrast, we found an overall rate of stress testing after PCI in the VA that was similar to previously reported rates of recurrent symptoms after PCI. Furthermore, we did not observe large temporal spikes in stress testing use at 6 months and 1 year.
Despite lower overall rates of stress testing use after PCI in the VA, we observed broad variation in facility-level rates of stress testing after PCI. Similar variation in facility-level use of stress testing has previously been described in the fee-for-service setting. 1 We observed minimal differences in patient and hospital characteristics by quartile of testing use to explain facility-level variation in stress testing and variation in facility-level rates of stress testing use persisted after risk-standardization. These findings suggest factors other than patient characteristics, reimbursement structure, and care delivery integration influence practice variation in the use of stress testing. This conclusion is further supported by recent studies that have demonstrated variation in the use of coronary procedures within the capitated healthcare delivery setting of Medicare Advantage. 19 Together, these findings suggest new models of care delivery that emphasize care integration and reimbursement design may be insufficient to eliminate unwarranted variation in care delivery. Within fee-for-service care settings, several studies have demonstrated a diagnostic to therapeutic cascade in which higher rates of diagnostic testing are associated with higher rates of therapeutic intervention, including higher rates of PCI at facilities with higher rates of diagnostic coronary angiography and stress testing. 1, 20, 21 In contrast to these findings, we observed an inverse relationship between VA facility rates of stress testing and subsequent use of coronary angiography and PCI. These findings suggest a diagnostic to therapeutic cascade for CAD management is less prevalent within the VA. Furthermore, coronary angiography and PCI before stress testing was more common at facilities with lower rates of stress testing use. These findings suggest invasive diagnostic strategies may partially replace noninvasive approaches at VA facilities with lower rates of stress testing use; however, the rates of coronary angiography and PCI were not high enough to explain the entirety of lower stress testing use at these facilities. Regardless, these findings suggest practice variation in the approach to longitudinal management of patients after PCI within the VA. Previous studies from non-VA settings have implicated supply of healthcare services, local practice culture, and profession norms as contributing to this type of practice variation. 5, 6, 22, 23 Certain aspects of VA care delivery, including the absence of financial incentives for hospitals and physicians to perform stress tests, as well as local constraints on the supply of nuclear medicine studies in fixed-budget hospitals, may contribute to lower rates of use. Understanding not only the factors that contribute to lower use of these services within the VA but those factors that contribute to variation in the VA (eg, availability of stress testing, culture, and practice norms) may inform opportunities to achieve the more consistent, effective, and efficient care delivery.
A challenge to understanding facility-level variation in the use of stress testing after PCI is whether this reflects procedural overuse or underuse of care. Similar to previous studies from Medicare populations, 1, 24, 25 we found few stress tests lead to subsequent coronary angiography or PCI and facility-level rates of stress testing are not associated with clinical outcomes of death or MI. Together, these findings may reflect overuse at facilities with high rates of stress testing. However, the clinical implications of stress testing are not limited to death and MI, but also include management of recurrent angina. Similar to previous studies of procedural use for CAD, 1, 24, 25 we lack data on longitudinal symptom status to understand the relationship between rates of stress testing and patient symptom burden. Whether variation in stress testing predominantly reflects underuse of overuse of care requires further study that incorporates measures of patient-reported symptom burden.
Our study should be considered in light of the following limitations. First, we assigned patients and their subsequent use of stress tests to the medical center that performed the index PCI regardless of their site of follow-up care. This approach is not unreasonable within the VA in which patients are referred from non-PCI medical centers and communitybased clinics to specific centers for specialty care in a huband-spoke care delivery model. As such, the attribution of stress tests to a PCI center reflects use within a given integrated care delivery hub-and-spoke system and our findings suggest variation in the use of stress tests across these networks of care delivery. In addition, attribution of post-PCI stress tests to the PCI center mirrors the methods of previous studies from fee-for-service care delivery settings. 1 However, this approach may obscure variation in the use of stress testing that relates to patients receiving longitudinal care in a variety of settings (ie, PCI centers, medical centers without PCI capabilities, or community-based outpatient clinics) and future study of the implications of the site of longitudinal care on the use of cardiac stress tests and imaging is warranted. Furthermore, this approach does not account for patients moving within the VA healthcare system, however, this type of patient movement would result in misclassification that should bias our findings toward the null. Second, our analysis accounts for care provided by VA facilities and non-VA facilities when the VA paid for the care. We cannot exclude the potential for differences in patient use of non-VA services that are not captured in VA administrative data. However, we have minimized this potential by excluding patients eligible for coverage under Medicare services. Third, despite the use of robust clinical data, this observational analysis is subject to the potential for residual confounding. Finally, as discussed above, patient symptom burden is a major contributor to decisions to perform diagnostic CAD procedures, such as stress tests. Similar to previous studies, we lack data on symptoms at the time of follow-up stress testing. Future efforts are needed to capture longitudinal patient symptom burden and thereby address this knowledge gap. 
